About Clindataceutics
It operates as a B2B and Consulting Services. The company has 6 employees. Clindataceutics offers products and services including Clinical Trial Management, Data and Analysis Services, CDISC Consulting, Regulatory Services, and Medical Writing. Clindataceutics operates in a competitive market with competitors including Charles River Laboratories, Cytel, LabCorp, Precision Medicine Group and Frontage Laboratories, among others.
- Employees 6
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website clindataceutics.com
- Legal Name Clindataceutics Private Limited
- Date of Incorporation 22 Feb, 2018
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹19.8 Lakh
FY 2022 · 0% YoY
- Net Loss-₹7.1 Lakh
FY 2022 · -36% margin
- EBITDA-₹9.7 Lakh
FY 2022 · -49% margin
- Employee Count6
Associated legal entities of Clindataceutics
Clindataceutics operates through Clindataceutics Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2022) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Clindataceutics Private Limited CIN U33100TG2018PTC122446 | Active | 22 Feb 2018 | Hyderabad, Telangana | ₹0.2 Cr | 6 | 2 | View details |
Products & Services of Clindataceutics
Clindataceutics offers a comprehensive portfolio of products and services, including Clinical Trial Management, Data and Analysis Services, CDISC Consulting, Regulatory Services, and Medical Writing.
Manages phases II to IV trials for drug development.
Provides biostatistics and clinical data handling.
Offers standards for clinical data interchange.
Assists with regulatory submissions and approvals.
Prepares reports and documents for trials.
Board of directors of Clindataceutics Private Limited (Clindataceutics)
Clindataceutics Private Limited is the primary company behind Clindataceutics. The board of Clindataceutics Private Limited currently have 2 directors; the longest-serving is Naresh Namani, appointed in 2018. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Naresh Namani DIN 08072824 | Director | 22 Feb 2018 | 8 yrs 7 mo | Clindataceutics Private Limited |
| Suresh Azmeera DIN 08400882 | Director | 24 Mar 2022 | 4 yrs 6 mo | Clindataceutics Private Limited |
Financials of Clindataceutics
Figures of Clindataceutics Private Limited, the primary company behind Clindataceutics, for FY 2022. Revenue was ₹19.8 Lakh (0% year on year). Net loss was -₹7.1 Lakh (-36% margin). EBITDA was -₹9.7 Lakh (-49% margin). Revenue has grown at a compounded annual rate of +3% over three years.
- ₹19.8 LakhRevenue · FY 2022 · 0% YoY
- -₹7.1 LakhNet loss · -36% margin
- -₹9.7 LakhEBITDA · -49% margin
- ₹1 LakhPaid-up capital
- 6Employees (provident fund records)
- +3%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Clindataceutics Private Limited are on its company page.
Detailed financial statements for Clindataceutics
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Clindataceutics
Clindataceutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Charles River Laboratories, Cytel, LabCorp, Precision Medicine Group and Frontage Laboratories, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| criver.com | 1947 | Wilmington, United States | – | 21,400 | Provider of drug discovery and preclinical development services | |
| cytel.com | 1987 | Cambridge, United States | $2M | 509 | Data analysis and statistical solutions are provided for life sciences. | |
| labcorp.com | 1969 | Burlington, United States | – | 9,321 | Provider of laboratory tests for physicians | |
| precisionmedicinegrp.com | 2012 | Bethesda, United States | $257.21M | 2,151 | Provider of clinical research, development, and commercialization services for life sciences | |
| frontagelab.com | 2001 | Exton, United States | $10.24M | – | Early drug development services are provided for pharma firms. | |
| precisionformedicine.com | 2013 | Bethesda, United States | $150M | – | Company offering specialised R&D and clinical development services for the development of precision medicine based drugs and devices | |
| canopybiosciences.com | 2016 | St. Louis, United States | $4.48M | – | Cell line engineering services are offered via CRISPR-Cas9 technology. | |
| taimei.com | 2013 | Pleasanton, United States | $193.73M | – | A digital intelligence platform is focused on life sciences activities. | |
| scantox.com | 1977 | Lille Skensved, Denmark | $6.29M | 30 | Laboratory focused on providing pharmacology, toxicology, and histopathology services | |
| tenpointtherapeutics.com | 2020 | Cambridge, United Kingdom | $70M | – | Engineered cell-based therapeutics are developed to restore vision. |
Detailed competitors of Clindataceutics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Clindataceutics
10 companies that operate in the same segment as Clindataceutics (Clinical Trials & Research Tech), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Genetic services are provided by Colossal's laboratory operations. | 2021 | Austin, Texas, United States | USD 617.6 M | – | – | |
Research lab engaged in pharmacological measurements on therapeutic protein variants | 2018 | United States | USD 78.19 M | – | 22 | |
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare. | 2004 | Ahmedabad, Gujarat, India | – | USD 50.52 M | 902 | |
Generic injectables for oncology and anesthesiology are manufactured. | 1989 | Hyderabad, Telangana, India | – | USD 4.22 M | 228 | |
Medical research labs are provided by GALY for scientific purposes. | 2018 | Boston, Massachusetts, United States | USD 61.59 M | – | 25 | |
Laboratory focused on biotechnology & molecule research services | 2018 | Cambridge, Massachusetts, United States | USD 32.68 M | – | – | |
Laboratory delivers discovery & research in nuclear and particle physics | 1947 | United States | – | – | 2,436 | |
Research and manufacturing of hemp products are conducted by BRC. | 2017 | Monterey, California, United States | USD 25.26 M | – | 16 | |
Genome sequencing studies are conducted for medical research purposes. | 2020 | Cambridge, Cambridgeshire, United Kingdom | USD 11.26 M | – | 12 | |
Novel immunotherapy therapeutic targets are discovered through laboratory research. | 2019 | Branford, Connecticut, United States | USD 92 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Clindataceutics
Clindataceutics has 6 employees.
The primary company behind Clindataceutics, Clindataceutics Private Limited, reported revenue of ₹19.8 Lakh for FY 2022, down 0% year on year.
Clindataceutics delivers specialized services in clinical research, including trial management, data analysis, and CDISC compliance. They handle biostatistics, statistical programming, and medical writing to support drug development. Operating from India, USA, and Canada, they assist clients with regulatory submissions and innovative medicine processes through experienced teams.
Clindataceutics's top competitors include LabCorp, Charles River Laboratories and Cytel.
Clindataceutics offers Clinical Trial Management, Data and Analysis Services, CDISC Consulting, Regulatory Services, and Medical Writing.
Clindataceutics operates through Clindataceutics Private Limited.
The legal entities of Clindataceutics currently have 2 directors, including Naresh Namani, Suresh Azmeera.